rs2133402
From SNPedia
| Orientation | minus |
| Stabilized | minus |
| Make rs2133402(A;A) |
| Make rs2133402(A;C) |
| Make rs2133402(C;C) |
| Reference | GRCh38.p7 38.3/149 |
| Chromosome | 3 |
| Position | 214575 |
| Gene | CHL1 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs2133402 |
| dbSNP (classic) | rs2133402 |
| ClinGen | rs2133402 |
| ebi | rs2133402 |
| HLI | rs2133402 |
| Exac | rs2133402 |
| Gnomad | rs2133402 |
| Varsome | rs2133402 |
| LitVar | rs2133402 |
| Map | rs2133402 |
| PheGenI | rs2133402 |
| Biobank | rs2133402 |
| 1000 genomes | rs2133402 |
| hgdp | rs2133402 |
| ensembl | rs2133402 |
| geneview | rs2133402 |
| scholar | rs2133402 |
| rs2133402 | |
| pharmgkb | rs2133402 |
| gwascentral | rs2133402 |
| openSNP | rs2133402 |
| 23andMe | rs2133402 |
| SNPshot | rs2133402 |
| SNPdbe | rs2133402 |
| MSV3d | rs2133402 |
| GWAS Ctlg | rs2133402 |
| Max Magnitude | 0 |
| ? | (A;A) (A;C) (C;C) | 28 |
|---|---|---|
|
| ||
[PMID 28260126] Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.
